Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (346) 346
Publication (42) 42
Book Chapter (8) 8
Patent (6) 6
Conference Proceeding (4) 4
Book / eBook (2) 2
Book Review (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (184) 184
index medicus (104) 104
female (93) 93
male (74) 74
adult (57) 57
middle aged (57) 57
animals (41) 41
amino acid sequence (36) 36
biochemistry & molecular biology (35) 35
aged (30) 30
molecular sequence data (30) 30
identification (29) 29
research (29) 29
cardiac & cardiovascular systems (26) 26
proteins (26) 26
biochemical research methods (25) 25
peptides (23) 23
cell biology (22) 22
cell line (20) 20
immunology (20) 20
neurosciences (20) 20
magnetic resonance imaging (19) 19
multidisciplinary sciences (19) 19
surgery (19) 19
adolescent (18) 18
mass spectrometry (18) 18
mice (18) 18
obstetrics & gynecology (18) 18
article (17) 17
ligands (16) 16
mortality (16) 16
pregnancy (16) 16
transplantation (16) 16
treatment outcome (16) 16
analysis (15) 15
base sequence (15) 15
antigen presentation (14) 14
expression (14) 14
psychiatry (14) 14
cloning, molecular (13) 13
fmri (13) 13
follow-up studies (13) 13
heart failure (13) 13
mass-spectrometry (13) 13
medicine, general & internal (13) 13
peptides - immunology (13) 13
phosphorylation (12) 12
retrospective studies (12) 12
risk factors (12) 12
transcription, genetic (12) 12
binding (11) 11
dna (11) 11
genes (11) 11
major histocompatibility complex (11) 11
peptides - chemistry (11) 11
peptides - metabolism (11) 11
proteomics (11) 11
respiratory system (11) 11
young adult (11) 11
abridged index medicus (10) 10
ankylosing-spondylitis (10) 10
antigen (10) 10
cancer (10) 10
cells (10) 10
gene expression (10) 10
gene-expression (10) 10
hla-b27 (10) 10
management (10) 10
prefrontal cortex (10) 10
proteomics - methods (10) 10
activation (9) 9
cardiovascular system (9) 9
class-i molecules (9) 9
genetic transcription (9) 9
heart failure - mortality (9) 9
histocompatibility antigen hla (9) 9
histocompatibility antigens class i - immunology (9) 9
immunotherapy (9) 9
mutation (9) 9
research article (9) 9
aged, 80 and over (8) 8
amino acids (8) 8
aminopeptidases - genetics (8) 8
amygdala (8) 8
brain (8) 8
brain mapping (8) 8
cell line, tumor (8) 8
cells, cultured (8) 8
coronary angiography (8) 8
degradation (8) 8
depression (8) 8
disease (8) 8
dna-binding proteins - metabolism (8) 8
functional magnetic resonance imaging (8) 8
israel (8) 8
physiological aspects (8) 8
prognosis (8) 8
prospective studies (8) 8
protein binding (8) 8
rats (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome
by Gotsman, Israel and Shauer, Ayelet and Zwas, Donna R and Hellman, Yaron and Keren, Andre and Lotan, Chaim and Admon, Dan
European Journal of Heart Failure, ISSN 1388-9842, 04/2012, Volume 14, Issue 4, pp. 357 - 366
Aims Vitamin D deficiency is a highly prevalent, global phenomenon. The prevalence in heart failure (HF) patients and its effect on outcome are less clear. We... 
Heart failure | Vitamin D | Season | Outcome | CARDIAC & CARDIOVASCULAR SYSTEMS | CORONARY-ANGIOGRAPHY | HYPOVITAMINOSIS-D | CALCIUM SUPPLEMENTATION | NUTRITION EXAMINATION SURVEY | 3RD NATIONAL-HEALTH | CARDIOVASCULAR-DISEASE | SERUM 25-HYDROXYVITAMIN-D | PARATHYROID-HORMONE | 1,25-DIHYDROXYVITAMIN D-3 | D INSUFFICIENCY | Multivariate Analysis | Confidence Intervals | Prevalence | Prognosis | Prospective Studies | Vitamin D Deficiency - complications | Humans | Middle Aged | Male | Treatment Outcome | Heart Failure - pathology | Heart Failure - drug therapy | Vitamin D Deficiency - epidemiology | Israel - epidemiology | Statistics, Nonparametric | Survival Analysis | Vitamin D Deficiency - pathology | Female | Aged | Vitamin D - therapeutic use | Dietary Supplements | Heart Failure - mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical Impact of ABO and Rhesus D Blood Type Groups in Patients With Chronic Heart Failure
by Gotsman, Israel and Keren, Andre and Zwas, Donna R and Lotan, Chaim and Admon, Dan
The American Journal of Cardiology, ISSN 0002-9149, 08/2018, Volume 122, Issue 3, pp. 413 - 419
Blood group systems based on red blood cell antigens are genetically determined and can identify patients at risk. Type non-O of the ABO blood group system has... 
RHAG PROTEIN | SURVIVAL | RISK | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DISEASE | Heart | Prognosis | Laboratories | Cardiomyopathy | Health services | Cardiovascular disease | D antigen | Gender | Blood | Data bases | Confidence intervals | Body mass index | Red blood cells | Ischemia | Thromboembolism | Drug therapy | Heart diseases | Blood groups | Age | Heart failure | Hypertension | Antigens | Enzymes | Statistical analysis | Mortality | Coronary artery | ABO system | Regression analysis | Coronary artery disease | Patients | Thrombosis | Survival analysis | Ethnicity | Health maintenance organizations--HMOs | Medical prognosis | Diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties
by Admon, R and Nickerson, L.D and Dillon, D.G and Holmes, A.J and Bogdan, R and Kumar, P and Dougherty, D.D and Iosifescu, D.V and Mischoulon, D and Fava, M and Pizzagalli, D.A
Psychological Medicine, ISSN 0033-2917, 01/2015, Volume 45, Issue 1, pp. 121 - 131
Background. Individuals with major depressive disorder (MDD) are characterized by maladaptive responses to both positive and negative outcomes, which have been... 
reward | PPI | treatment prediction | Caudate | cingulate | depression | POSITIVE AFFECT | ACTIVATION | PSYCHIATRY | PERFORMANCE | FUNCTIONAL CONNECTIVITY | PSYCHOPHYSIOLOGICAL INTERACTIONS | PSYCHOLOGY, CLINICAL | PSYCHOLOGY | NEURAL RESPONSES | DECISION-MAKING | DISORDER | UNIPOLAR DEPRESSION | Punishment | Depressive Disorder, Major - physiopathology | Corpus Striatum - physiopathology | Humans | Middle Aged | Male | Treatment Outcome | Antidepressive Agents, Second-Generation - therapeutic use | Case-Control Studies | Depressive Disorder, Major - psychology | Magnetic Resonance Imaging | Regression Analysis | Psychiatric Status Rating Scales | Motivation | S-Adenosylmethionine - therapeutic use | Gyrus Cinguli - physiopathology | Adult | Citalopram - therapeutic use | Female | Depressive Disorder, Major - diagnosis | Depressive Disorder, Major - drug therapy | Brain | Nuclear magnetic resonance--NMR | Mental depression | Rewards | Depression | Treatment Prediction | gPPI | Reward | Cingulate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
by Berry, C and Doughty, RN and Granger, C and Kober, L and Massie, B and McAlister, F and McMurray, J and Pocock, S and Poppe, K and Swedberg, K and Somaratne, J and Whalley, GA and Ahmed, A and Andersson, B and Bayes-Genis, A and Cowie, M and Cubbon, R and Ezekowitz, J and Gonzalez-Juanatey, J and Gorini, M and Gotsman, I and Grigorian-Shamagian, L and Guazzi, M and Kearney, M and Komajda, M and di Lenarda, A and Lenzen, M and Lucci, D and Macin, S and Madsen, B and Maggioni, A and Martinez-Selles, M and Oliva, F and Rich, M and Richards, M and Senni, M and Squire, I and Taffet, G and Tarantini, L and Tribouilloy, C and Troughton, R and Tsutsui, H and Earle, N and Perera, K and Dobson, J and Whalley, G and Hall, C and Richards, AM and Lainchbury, J and Hogg, K and Norrie, J and Stevenson, K and Brett, M and Pfeffer, MA and Granger, CB and Held, P and McMurray, JJV and Michelson, EL and Olofsson, B and Ostergren, J and Yusuf, S and Torp-Pedersen, C and Lenzen, MJ and Reimer, WJMS and Boersma, E and Vantrimpont, PJMJ and Follath, F and Cleland, J and Zwas, D and Planer, D and Azaz-Livshits, T and Admon, D and Lotan, C and Keren, A and Varela-Roman, A and Mazon-Ramos, P and Rigeiro-Veloso, P and Bandin-Dieguez, MA and Gonzalez-Juanatey, JR and Myers, J and Arena, R and McAlister, FA and Armstrong, PW and Cujec, B and Paterson, I and Cowie, MR and Wood, DA and Coats, AJS and Thompson, SG and Suresh, V and Poole-Wilson, PA and Sutton, GC and Robles, JAG and Prieto, L and Munoa, MD and Frades, E and Diaz-Castro, O and Almendral, J and Faggiano, P and Bertoli, D and ... and MAGGIC Coordinating Ctr and MAGGIC Stat Grp and MAGGIC Studies & Investigators and CHARM Investigators & Comm and Meta-Anal Global Grp Chronic Heart and MAGGIC Steering Grp and Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 07/2012, Volume 33, Issue 14, pp. 1750 - 1757
A substantial proportion of patients with heart failure have preserved left ventricular ejection fraction (HF-PEF). Previous studies have reported mixed... 
Heart failure | MORTALITY | DIAGNOSIS | HOSPITALIZED-PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | Prognosis | DEATH | SYSTOLIC FUNCTION | NATRIURETIC PEPTIDE | Meta-analysis | READMISSION | CANDESARTAN | ELDERLY-PATIENTS | Humans | Risk Factors | Heart Failure - physiopathology | Stroke Volume - physiology | Female | Male | Aged | Cause of Death | Heart Failure - mortality | Randomized Controlled Trials as Topic | physiology | Kardiologi | Stroke Volume | Cardiac and Cardiovascular Systems | physiopathology | Heart Failure | mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
by McMurray, John J. V and Anand, Inder S and Diaz, Rafael and Maggioni, Aldo P and O'Connor, Christopher and Pfeffer, Marc A and Solomon, Scott D and Tendera, Michal and van Veldhuisen, Dirk J and Albizem, Moetaz and Cheng, Sunfa and Scarlata, Debra and Swedberg, Karl and Young, James B and RED-HF Comm Investigators and RED-HF Committees Investigators and on behalf of the RED-HF Committees Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
European Journal of Heart Failure, ISSN 1388-9842, 03/2013, Volume 15, Issue 3, pp. 334 - 341
Aims This report describes the baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) which is... 
Heart failure | MORTALITY | TREATMENT OPTIONS | Anaemia | MORBIDITY CHARM PROGRAM | DOUBLE-BLIND | CARDIAC-RESYNCHRONIZATION THERAPY | RANDOMIZED CONTROLLED-TRIAL | IRON-DEFICIENCY | ANEMIA | CHRONIC KIDNEY-DISEASE | HEALTH-STATUS | HEMOGLOBIN | CARDIAC & CARDIOVASCULAR SYSTEMS | METOPROLOL | IMPACT | MORBIDITY | CANDESARTAN | Severity of Illness Index | Heart Failure - complications | Anemia - mortality | Demography - statistics & numerical data | Clinical Trials as Topic - statistics & numerical data | Double-Blind Method | Hematinics - therapeutic use | Comorbidity | Erythropoietin - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Cause of Death | Erythropoietin - analogs & derivatives | Anemia - complications | Anemia - drug therapy | Aged, 80 and over | Female | Aged | Darbepoetin alfa | Heart Failure - mortality | Clinical Trials | Clinical Medicine | chronic heart failure | Klinisk medicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis
by Jackson, Colette E and Castagno, Davide and Maggioni, Aldo P and Køber, Lars and Squire, Iain B and Swedberg, Karl and Andersson, Bert and Richards, A. Mark and Bayes-Genis, Antoni and Tribouilloy, Christophe and Dobson, Joanna and Ariti, Cono A and Poppe, Katrina K and Earle, Nikki and Whalley, Gillian and Pocock, Stuart J and Doughty, Robert N and McMurray, John J.V and Meta-Anal Global Grp Chronic He and Meta-Analysis Global Group in Chronic Heart Failure MAGGIC and Meta-Analysis Global Group in Chronic Heart and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
European Heart Journal, ISSN 0195-668X, 05/2015, Volume 36, Issue 18, pp. 1106 - 1114
Aims Low pulse pressure is a marker of adverse outcome in patients with heart failure (HF) and reduced ejection fraction (HF-REF) but the prognostic value of... 
Heart failure | Pulse pressure | Preserved ejection fraction | Mortality | Reduced ejection fraction | SURVIVAL | INDEPENDENT PREDICTOR | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | DIFFERENTIAL IMPACT | BLOOD-PRESSURE | WAVE VELOCITY | ACUTE MYOCARDIAL-INFARCTION | ASSOCIATION | ONSET ATRIAL-FIBRILLATION | Heart Failure - complications | Acute Disease | Prognosis | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Cause of Death | Randomized Controlled Trials as Topic | Hypertension - complications | Observational Studies as Topic | Female | Hypertension - mortality | Chronic Disease | Heart Failure - mortality | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Actively personalized vaccination trial for newly diagnosed glioblastoma
by Hilf, Norbert and Kuttruff-Coqui, Sabrina and Frenzel, Katrin and Bukur, Valesca and Stevanović, Stefan and Gouttefangeas, Cécile and Platten, Michael and Tabatabai, Ghazaleh and Dutoit, Valerie and van der Burg, Sjoerd H and thor Straten, Per and Martínez-Ricarte, Francisco and Ponsati, Berta and Okada, Hideho and Lassen, Ulrik and Admon, Arie and Ottensmeier, Christian H and Ulges, Alexander and Kreiter, Sebastian and von Deimling, Andreas and Skardelly, Marco and Migliorini, Denis and Kroep, Judith R and Idorn, Manja and Rodon, Jordi and Piró, Jordi and Poulsen, Hans S and Shraibman, Bracha and McCann, Katy and Mendrzyk, Regina and Löwer, Martin and Stieglbauer, Monika and Britten, Cedrik M and Capper, David and Welters, Marij J. P and Sahuquillo, Juan and Kiesel, Katharina and Derhovanessian, Evelyna and Rusch, Elisa and Bunse, Lukas and Song, Colette and Heesch, Sandra and Wagner, Claudia and Kemmer-Brück, Alexandra and Ludwig, Jörg and Castle, John C and Schoor, Oliver and Tadmor, Arbel D and Green, Edward and Fritsche, Jens and Meyer, Miriam and Pawlowski, Nina and Dorner, Sonja and Hoffgaard, Franziska and Rössler, Bernhard and Maurer, Dominik and Weinschenk, Toni and Reinhardt, Carsten and Huber, Christoph and Rammensee, Hans-Georg and Singh-Jasuja, Harpreet and Sahin, Ugur and Dietrich, Pierre-Yves and Wick, Wolfgang
Nature, ISSN 0028-0836, 01/2019, Volume 565, Issue 7738, pp. 240 - 245
Patients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in cancer treatment that use checkpoint inhibitors(1,2). For... 
TUMOR-INFILTRATING LYMPHOCYTES | IMMUNE-RESPONSE | T-CELL RESPONSES | MELANOMA | MULTIDISCIPLINARY SCIENCES | PATIENT | MUTATIONS | IDENTIFICATION | CANCER | MULTIFORME | TEMOZOLOMIDE | Flow cytometry | Peptides | CD8 antigen | Vaccination | Customization | L-lysine | Glioblastoma | Amino acids | Lymphocytes T | Vaccines | Granulocyte-macrophage colony stimulating factor | Cancer therapies | Metastases | Exploitation | Consortia | Hepatitis | Poly-L-lysine | Granulocytes | Lymphocytes | Immunotherapy | Colony-stimulating factor | Carboxymethylcellulose | Antigens | Immunological memory | Memory cells | Granulocyte-macrophage colony-stimulating factor | Good Manufacturing Practice | Melanoma | Adjuvants | Patients | CD4 antigen | White blood cells | Immune checkpoint | Glioma | Immunogenicity | Lysine | Ligands | Infiltration | Scientific imaging | Histocompatibility antigen HLA | Mutation | Mass spectrometry | Viral infections | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis
by Berry, C and Poppe, K.K and Gamble, G.D and Earle, N.J and Ezekowitz, J.A and Squire, I.B and McMurray, J.J.V and McAlister, F.A and Komajda, M and Swedberg, K and Maggioni, A.P and Ahmed, A and Whalley, G.A and Doughty, R.N and Tarantini, L and Granger, C and Køber, L and Massie, B and Pocock, S and Somaratne, J and Andersson, B and Bayes-Genis, A and Cowie, M and Cubbon, R and Gonzalez-Juanatey, J and Gorini, M and Gotsman, I and Grigorian-Shamagian, L and Guazzi, M and Kearney, M and Di Lenarda, A and Lenzen, M and Lucci, D and Macín, S and Madsen, B and Martínez-Sellés, M and Oliva, F and Rich, M and Richards, M and Senni, M and Taffet, G and Tribouilloy, C and Troughton, R and Tsutsui, H and Ariti, C and Dobson, J and Hall, C and Lainchbury, J and Hogg, K and Norrie, J and Stevenson, K and Brett, M and Pfeffer, M.A and Held, P and Michelson, E.L and Olofsson, B and Östergren, J and Yusuf, S and Torp-Pedersen, C and Scholte op Reimer, W and Boersma, E and Vantrimpont, P.J.M.J and Follath, F and Cleland, J and Zwas, D and Planer, D and Azaz-Livshits, T and Admon, D and Lotan, C and Keren, A and Varela-Roman, A and Mazón-Ramos, P and Rigeiro-Veloso, P and Bandin-Dieguez, M.A and Myers, J and Arena, R and Armstrong, P.W and Cujec, Bibiana and Paterson, Ian and Wood, D.A and Coats, A.J.S and Thompson, S.G and Suresh, V and Poole-Wilson, P.A and Sutton, G.C and Robles, J.A.G and Prieto, L and Muñoa, M.D and Frades, E and Díaz-Castro, O and Almendral, J and Faggiano, P and Bertoli, D and Porcu, M and Opasich, C and Tavazzi, L and Kirk, V and Bay, M and Parner, J and Krogsgaard, K and ... and MAGGIC Collaborative Grp and MAGGIC Collaborative Group and On Behalf Of The MAGGIC Collaborative Group and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
QJM, ISSN 1460-2725, 2016, Volume 109, Issue 6, pp. 377 - 382
Background: Anaemia is common among patients with heart failure (HF) and is an important prognostic marker. Aim: We sought to determine the prognostic... 
MORTALITY | TRIAL | MEDICINE, GENERAL & INTERNAL | ARTERIAL STIFFNESS | DISEASE | IRON | SEX-DIFFERENCES | PREVALENCE | OUTCOMES | HEMOGLOBIN LEVEL | DARBEPOETIN-ALPHA | Heart Failure - complications | Anemia - mortality | Prognosis | Prospective Studies | Humans | Heart Failure - physiopathology | Proportional Hazards Models | Stroke Volume - physiology | Male | Cause of Death | Anemia - physiopathology | Anemia - complications | Female | Aged | Heart Failure - diagnosis | Heart Failure - mortality | Original Papers | Klinisk medicin | Clinical Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Monday, 27 August 2012
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and